RareSum
PrivateLast Round
Pre Seed
Mar 1, 2025
Total Funding Raised
$150,000
Company Overview
RareSum is a health-tech company that provides an AI-powered clinical decision support platform to assist physicians in the early diagnosis of rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RareSum Comparables
Compare RareSum with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenEngine | 81% | |
| Volv Global | 80% | |
| ThinkGenetic, Inc. | 78% |
RareSum Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 1, 2025 | ||||
| Seed | Feb 19, 2025 | ||||
| Accelerator | Oct 1, 2024 |
Key People
Founding team and executive leadership
RareSum Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sabancı ARF | Accelerator, Pre Seed |
| Techventure VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2025
Raised a Seed round with Techventure VC participating.
- Oct 1, 2024
$30K round from Sabancı ARF
RareSum Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RareSum's valuation, stock price, and market status.
Is RareSum a public or private company?
RareSum is a private company.
What is the current stock price of RareSum?
RareSum is a private company with no public stock price. No recent secondary market data is available.
How much is RareSum worth (valuation)?
Valuation information for RareSum is not publicly available.
Can I buy RareSum stock?
RareSum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RareSum's last funding round?
RareSum's most recent funding round was Pre Seed on March 1, 2025.
Who are the main investors in RareSum?
Key investors in RareSum include Sabancı ARF.
Will RareSum IPO soon?
No public IPO plans have been announced for RareSum.
How can I track RareSum secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RareSum's secondary market activity and sign up for updates.